Optic Neuritis Completed Phase 4 Trials for Interferon beta-1a (DB00060)

Also known as: Optical Neuritis / Unspecified optic neuritis / Optic neuritis NOS / Optic neuritis, unspecified / Neuritis optic

IndicationStatusPhase
DBCOND0027863 (Optic Neuritis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00179478Long Term Study of Avonex Therapy Following a First Attack of Multiple SclerosisTreatment